Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Deep Learning for Detection of Pulmonary Hypertension and Reduced Left Ventricular Ejection Fraction Using a Combined Digital Stethoscope and Three-lead Electrocardiogram

NCT07087613 is registered in ClinicalTrials.gov with Eko Devices, Inc. as lead sponsor.

NCT NCT07087613
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07087613 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Deep Learning for Detection of Pulmonary Hypertension and Reduced Left Ventricular Ejection Fraction Using a Combined Digital Stethoscope and Three-lead Electrocardiogram
Lead sponsor
Eko Devices, Inc.
Phase
Observational
Overall status
Recruiting
Start date
June 15, 2025
Completion date
May 31, 2027
Enrollment
3,850 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure with reduced ejection fraction, hypertension, pulmonary